• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/16

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

16 Cards in this Set

  • Front
  • Back
Treatment of Tuberculosis (1st-line, and side effects)
1st line drugs in order of use:

Isoniazid (INH) "I SAW A... Rifampin "RED" Pyrazinamide "PYRE BURNING THE LIVER."

ES (Ethambutol and Streptomycin)

RIP | ES "RIPES" works too.

Since I saw a red Pyre burning the liver, these first-line agents can cause liver damage.
2 types of TB populations that you will treat
1. Those with active tuberculosis
2. Those with a reactive PPD skin test, representing a latent infection
Tx.of active Tuberculosis
6 month regimin-->2 months of isoniazid, rifampin, and pyrazinamide + 4 mos. isoniazid and rifampin

9-monh regimin-->9 months of isoniazid and rifampin.

Pyrazinamide is in the shorter treatment regimin, and is rapidly bacteriocidal to M. TB, but if used longer than 2 months, then risk of liver toxicity too high! "LIVER ON PYRE!"
Tx. of those witha positive PPD skin test
Preventative tx. is initiated in case they are in latency.

Isoniazid is used alone 6-12 months (prophylaxis), but rifampin +pyrazinamide for 2 months may be just as effective.

Balance risk of developing isoniazid-induced liver injury with the with the risk of reactivation TB.
Factors that increase the risk of reactivation TB include:
1. recent PPD conversion
2. having fibrotic scars on chest x-ray
3. exposure to household members with active TB
4. Being immunosuppressed.
Differences in treatment between high/low TB-activation risk groups?
Greatest risk of activation (PPD>5mm)
1. HIV infxn
2. Fibrotic changes on CXR
3. Close contacts with newly diagnosed active TB. in case # 3 tx for 3 mos. is needed even if PPD is negative.

MODERATE RISK (any age if PPD is >10mm

1. persons with med conditions (diabetes, prolonged steroid tx., renal failure) that lower the immune system.
2. Persons with recent skin test conversion within the last 2 years
3. Persons who inject drugs

LESS RISK: Patients if age <35 and PD >10mm:

High-risk populations such as homeless, residents of long-term care facilities, prisons/nursing homes, foreign born etc)

LOWEST RISK:

Tx. at physician's discretion if age <35. A person with no known risk factors and a PPD >15 mm.
Resistance to Isoniazid (INH)
Suspected of asians/africans/south americans, homeless person's, and patients who have sputum cultures that remain positive after 2 months of tx.

1. Culture susceptibility testing should follow the tx. initiation
2.If resistance is suspected, 4 or more 1st-line drugs should be used (INH, rifampin, pyrazinamide, ethambutol, or streptomycin-->RIPES)
3. If resistance develops, never add a single new antibiotic, always add two.
What is a common strategy that is used to prevent multiply resistant M. tuberculosis strains from developing?
DOT (Directly observed therapy)
Anti-TB antibiotics: (Isoniazid, Rifampin, and Pyrazinamide)= RIP

side effects, absorption, distribution
1. all cause hepatotoxicity--> patients must understand the symptoms of hepatitis and rpeort to physician immediately if they develop.

Mild elevations of liver enzymes can be expected to occur in 15-20% of patients on isoniazid, but should these levels exceed 3-5x the upper limit of normal, the drugs should be discontinued.

2. All are absorbed early: this is important since they must be adminsitered for 6-9 months. They must be orally absorbed!!!!!

3. All penetrate into most tissues-->and into the center of caseous granulomas.
Isoniazid (INH)

Mechanism of action.
Great drug! It's inexpensive, absorbed orally, and bacteriocidal. Were it not for the toxicity it would be perfect.

INH interferes with the biosynthesis of the mycolic acid component of the cell wall of the mycobacteria.
Adverse effects of Isoniazid (INH)
1. Hepatotoxicity

2. INH increases urinary excretion and depletion of pyridoxine (B6) which is needed for proper nerve function.

INH-->decreased B6 levels -->pellagra (peripheral neuropathy, rash anemia.)

B6 vitamins often coadministered with INH.
Rifampin
("Red") Think Rifampin:

1. Red: Body fluids such as urine, feces, salive, sweat, and tears are colored bright red-orange by rifampin. Not harmful, inform patient.
2. "R"NA: Rifampin inhibits the DNA-dependent RNA polymerase of the M. tuberculosis bugs.
Adverse effects of Rifampin
1. Hepatitis (must less than INH)
2. Rifampin induces cytochrome P450 enzyme system (microsomal oxidase system, or MOS). Overactive P450 gobbles up other drugs the patient is taking faster (increased half lives)

This can affect:
a. coumadin (anticoagulant)
b. oral contraceptives
c. oral hypoglycemics and corticosteroids
d. anticonvulsants such as phenytoin
Rifabutin
Similar to rifampin in structure, antibacterial activity, metabolism, and adverse reactions. Commonly used to treat mycobacterium avium intracellulare (MAI)-->MAI > sensitive to rifabutin than rifampin.
Pyrazinamide

Mechanism and adverse effects
The "P" or Ripe. The mechanism is not known, but there are adverse effects:

1. hepatotoxic (no kidding!?)

This medicine is usually given for no more than 2 months to avoid liver toxicity. Avoid in prenancy
Ethambutol
"Ethane-Butane Torch"

Adverse effects:
Main side effect is dose-dependent, reversible ocular toxicity.
1. Decreased visual acuity (central scotomata)
2. Color vision loss.


Ethambutol is not used in young children because they are not able to report vision deterioration.